Literature DB >> 23555495

Ischemic Colitis Following Transarterial Embolization for Type 2 Endoleak of EVAR: Report of a Case.

Toshiro Ito1, Yoshihiko Kurimoto, Nobuyoshi Kawaharada, Tetsuya Koyanagi, Toshiyuki Maeda, Yohsuke Yanase, Junji Nakazawa, Naoki Hirokawa, Tetsuya Higami.   

Abstract

A 71 year old man was diagnosed to have enlargement of abdominal aortic aneurysm due to type 2 endoleak two years after endovascular aneurysm repair (EVAR). 3D-CT demonstrated a type 2 endoleak that originated from the superior mesenteric artery that fed the inferior mesenteric artery and the right iliolumbar artery that flowed into the 4th lumbar artery. Transarterial embolization was performed by means of N-butyl-2-cyanoacrylate (NBCA). After the treatment, he suffered ischemic colitis that extended from the sigmoid colon to the descending colon. Conservative treatment was mainly performed, and clinical improvement was observed over time. He was discharged after 73 postoperative days.

Entities:  

Keywords:  ischemic colitis; transarterial embolization; type 2 endoleak

Year:  2012        PMID: 23555495      PMCID: PMC3595925          DOI: 10.3400/avd.cr.11.00081

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  13 in total

1.  Retroperitoneal endoscopic ligation of lumbar and inferior mesenteric arteries as a treatment of persistent endoleak after endoluminal aortic aneurysm repair.

Authors:  W Wisselink; M A Cuesta; F J Berends; F G van den Berg; J A Rauwerda
Journal:  J Vasc Surg       Date:  2000-06       Impact factor: 4.268

2.  Translumbar embolization of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms.

Authors:  R A Baum; C Cope; R M Fairman; J P Carpenter
Journal:  J Vasc Interv Radiol       Date:  2001-01       Impact factor: 3.464

3.  Deep circumflex iliac artery as a cause of type II endoleak.

Authors:  Lip Gen Teh; Greg van Schie; Kishore Sieunarine
Journal:  J Endovasc Ther       Date:  2003-02       Impact factor: 3.487

4.  Embolization of type II endoleaks after aortic stent-graft implantation: technique and immediate results.

Authors:  S Haulon; A Tyazi; S Willoteaux; M Koussa; C Lions; J P Beregi
Journal:  J Vasc Surg       Date:  2001-10       Impact factor: 4.268

5.  Successful embolization of persistent endoleak from a patent inferior mesenteric artery.

Authors:  G van Schie; K Sieunarine; M Holt; M Lawrence-Brown; D Hartley; M A Goodman; F J Prendergast; M Khangure
Journal:  J Endovasc Surg       Date:  1997-08

6.  Colonic necrosis subsequent to catheter-directed thrombin embolization of the inferior mesenteric artery via the superior mesenteric artery: a complication in the management of a type II endoleak.

Authors:  R L Bush; P H Lin; R S Ronson; B S Conklin; L G Martin; A B Lumsden
Journal:  J Vasc Surg       Date:  2001-12       Impact factor: 4.268

7.  Diagnosis and treatment of inferior mesenteric arterial endoleaks after endovascular repair of abdominal aortic aneurysms.

Authors:  R A Baum; J P Carpenter; C M Tuite; O C Velazquez; M C Soulen; C F Barker; M A Golden; A M Pyeron; R M Fairman
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

8.  Type 2 endoleak embolization comparison: translumbar embolization versus modified transarterial embolization.

Authors:  S William Stavropoulos; Jin Park; Ronald Fairman; Jeffrey Carpenter
Journal:  J Vasc Interv Radiol       Date:  2009-08-19       Impact factor: 3.464

9.  Ischemic colitis following translumbar thrombin injection for treatment of endoleak.

Authors:  Esteban Gambaro; Ahmed M Abou-Zamzam; Theodore H Teruya; Christian Bianchi; James Hopewell; Jeffrey L Ballard
Journal:  Ann Vasc Surg       Date:  2004-01-12       Impact factor: 1.466

10.  Type II endoleak after endovascular abdominal aortic aneurysm repair: a conservative approach with selective intervention is safe and cost-effective.

Authors:  Eric Steinmetz; Brian G Rubin; Luis A Sanchez; Eric T Choi; Patrick J Geraghty; Jack Baty; Robert W Thompson; M Wayne Flye; David M Hovsepian; Daniel Picus; Gregorio A Sicard
Journal:  J Vasc Surg       Date:  2004-02       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.